Leukemia, B-Cell  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00062296: Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Completed
2
5
US
rituximab, epirubicin hydrochloride
Fox Chase Cancer Center, National Cancer Institute (NCI)
Leukemia, Lymphoma
08/05
08/05

Download Options